Ascletis Pharma Inc
HKEX:1672

Watchlist Manager
Ascletis Pharma Inc Logo
Ascletis Pharma Inc
HKEX:1672
Watchlist
Price: 1.6 HKD -5.33% Market Closed
Market Cap: 1.6B HKD
Have any thoughts about
Ascletis Pharma Inc?
Write Note

Gross Margin
Ascletis Pharma Inc

-125.2%
Current
-1%
Average
63.9%
Industry

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
-125.2%
=
Gross Profit
-12.6m
/
Revenue
10.1m

Gross Margin Across Competitors

Country Company Market Cap Gross
Margin
CN
Ascletis Pharma Inc
HKEX:1672
1.6B HKD
-125%
FR
Pharnext SCA
OTC:PNEXF
6T USD
0%
US
Abbvie Inc
NYSE:ABBV
320.1B USD
67%
US
Amgen Inc
NASDAQ:AMGN
147.4B USD
60%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
119.4B USD
86%
US
Gilead Sciences Inc
NASDAQ:GILD
113.8B USD
78%
US
Epizyme Inc
F:EPE
94.1B EUR
76%
AU
CSL Ltd
ASX:CSL
135.4B AUD
52%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
82.6B USD
87%
US
Seagen Inc
F:SGT
39.3B EUR
75%
NL
argenx SE
XBRU:ARGX
34.3B EUR
89%
Country CN
Market Cap 1.6B HKD
Gross Margin
-125%
Country FR
Market Cap 6T USD
Gross Margin
0%
Country US
Market Cap 320.1B USD
Gross Margin
67%
Country US
Market Cap 147.4B USD
Gross Margin
60%
Country US
Market Cap 119.4B USD
Gross Margin
86%
Country US
Market Cap 113.8B USD
Gross Margin
78%
Country US
Market Cap 94.1B EUR
Gross Margin
76%
Country AU
Market Cap 135.4B AUD
Gross Margin
52%
Country US
Market Cap 82.6B USD
Gross Margin
87%
Country US
Market Cap 39.3B EUR
Gross Margin
75%
Country NL
Market Cap 34.3B EUR
Gross Margin
89%
No Stocks Found

Ascletis Pharma Inc
Glance View

Market Cap
1.6B HKD
Industry
Biotechnology

Ascletis Pharma, Inc. operates as biotechnology firm to test the waters. The company is headquartered in Hangzhou, Zhejiang and currently employs 266 full-time employees. The company went IPO on 2018-08-01. The firm is focused on three therapeutic areas, including anti-viral, cancer and fatty liver disease. The Company’s main products include drugs against hepatitis C virus (HCV), human immunodeficiency virus (HIV) and hepatitis B virus (HBV).

Intrinsic Value
0.7 HKD
Overvaluation 56%
Intrinsic Value
Price

See Also

Discover More
What is Gross Margin?

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
-125.2%
=
Gross Profit
-12.6m
/
Revenue
10.1m
What is the Gross Margin of Ascletis Pharma Inc?

Based on Ascletis Pharma Inc's most recent financial statements, the company has Gross Margin of -125.2%.